7.2 Risk factor assessment and risk stratification		COR	LOE
7.2.1 Assessment of blood pressure
Reworded	Blood pressure assessment should be conducted and strictly monitored after AIS.	I	A
Reworded	Blood pressure variability and pulse pressure have been suggested as potential factors associated with the prognosis of AIS. When monitoring blood pressure, attention should be paid to changes in these two indicators.	IIa	A
7.2.2 Evaluation of blood lipid
Unchanged	Dyslipidaemia (too high or too low) is closely related to poor prognosis. Serum lipid levels should be actively assessed after AIS to guide lipid-lowering treatment and secondary prevention.	IIa	B
Unchanged	Relatively low blood lipids may indicate a more severe condition of cerebral infarction, and attention should be paid to the changes in the patient’s condition.	IIb	C
7.2.3 Assessment of blood glucose
Reworded	Hyperglycaemia and blood glucose fluctuations after AIS are closely associated with stroke recurrence and poor prognosis. Strict monitoring and control of blood glucose levels in clinical practice are recommended.	IIa	B
New recommendation	It is reasonable for patients with IS or TIA to receive fasting glucose, HbA1c or oral glucose tolerance test (OGTT) screening to check for abnormal glucose metabolism after stroke. HbA1c should be used in the acute phase to screen for diabetes and pre-diabetes. Patients with no apparent history of diabetes or no precise diagnosis of diabetes should routinely receive OGTT screening for pre-diabetes and diabetes after the acute phase.	IIa	B
	Patients with abnormal glucose metabolism are at risk of diabetes and major adverse cardiovascular events. HbA1c, fasting plasma glucose and OGTT are available methods for glucose metabolism screening. HbA1c is probably the preferred diagnostic method, which is more convenient (ie, it does not require fasting) and has less variability over a short period, making it suitable for acute phase screening. OGTT can comprehensively evaluate fasting plasma glucose and 2-hour postprandial glucose, early detection of abnormal glucose metabolism and reduce the rate of missed diagnosis of diabetes.127